Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 5.74 EUR -1.03% Market Closed
Market Cap: 160.7m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Hyloris Pharmaceuticals SA

Current Assets 35.3m
Cash & Short-Term Investments 30.7m
Receivables 3.8m
Other Current Assets 804k
Non-Current Assets 12.4m
Long-Term Investments 4.8m
PP&E 2.2m
Intangibles 3.8m
Other Non-Current Assets 1.6m
Current Liabilities 6.8m
Accounts Payable 3.3m
Other Current Liabilities 3.4m
Non-Current Liabilities 1.9m
Long-Term Debt 1.5m
Other Non-Current Liabilities 343k

Balance Sheet
Hyloris Pharmaceuticals SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
0
3
0
64
50
43
30
Cash Equivalents
0
3
0
64
50
43
30
Short-Term Investments
0
0
0
0
1
10
0
Total Receivables
0
1
0
0
2
4
4
Accounts Receivables
0
0
0
0
2
4
4
Other Receivables
0
1
0
0
0
0
0
Other Current Assets
0
0
3
2
1
2
1
Total Current Assets
1
4
4
67
54
50
35
PP&E Net
0
0
0
0
0
1
2
PP&E Gross
0
0
0
0
0
1
2
Accumulated Depreciation
0
0
0
0
0
0
1
Intangible Assets
4
4
2
2
3
4
4
Long-Term Investments
0
0
0
0
5
5
5
Other Long-Term Assets
0
0
0
0
2
1
2
Total Assets
4
N/A
8
+82%
6
-25%
69
+1 056%
63
-8%
61
-4%
48
-21%
Liabilities
Accounts Payable
2
2
3
2
3
2
3
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
Other Current Liabilities
0
1
13
0
12
3
3
Total Current Liabilities
2
3
16
2
15
6
7
Long-Term Debt
0
0
0
0
0
1
2
Minority Interest
0
2
0
0
0
0
0
Other Liabilities
7
9
0
8
0
0
0
Total Liabilities
9
N/A
10
+18%
16
+59%
10
-37%
15
+52%
7
-56%
9
+26%
Equity
Common Stock
0
0
0
0
0
0
0
Retained Earnings
23
26
34
45
56
65
80
Additional Paid In Capital
18
24
24
104
104
122
122
Other Equity
0
0
0
0
0
3
2
Total Equity
4
N/A
2
+48%
10
-354%
59
N/A
48
-19%
54
+12%
39
-28%
Total Liabilities & Equity
4
N/A
8
+82%
6
-25%
69
+1 056%
63
-8%
61
-4%
48
-21%
Shares Outstanding
Common Shares Outstanding
18
18
18
26
26
28
28

See Also

Discover More